{
  "attach_pages": "43",
  "attach_size": "2929",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP202008311404521555_1.pdf?1598896813000.pdf",
  "company_code": "80050806",
  "eitime": "2020-08-31 18:00:13",
  "extend": {},
  "info_code": "AP202008311404521555",
  "language": "0",
  "notice_date": "2020-08-31 00:00:00",
  "notice_title": "下半年迎业绩拐点，仿创结合药品进入收获期",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "CCC",
  "researcher": "周豫",
  "security": [
    {
      "market_uni": "0",
      "publish_relation": [
        {
          "originalCode": "465",
          "publishName": "化学制药"
        }
      ],
      "short_name": "科伦药业",
      "short_name_ch": "科伦药业",
      "short_name_cht": "科倫藥業",
      "short_name_en": "KELUN PHARMA",
      "stock": "002422"
    }
  ],
  "short_name": "科伦药业",
  "source_sample_name": "太平洋",
  "star": "3"
}